Gerhard Johannes Paul Domagk (1895-1964) was a German pathologist and bacteriologist whose research at the IG Farben laboratories led to the discovery of the first commercially available antibacterial drug. Testing chemical dye compounds for therapeutic activity, he identified sulfonamidochrysoidine, marketed as Prontosil, as an effective treatment against streptococcal and other bacterial infections. Its efficacy became personally vivid to him in 1935 when he used the still-experimental drug to save his own daughter's arm, and likely her life, after she contracted a severe streptococcal infection. For this discovery he was awarded the 1939 Nobel Prize in Physiology or Medicine, though Nazi Germany's government forbade him from accepting it at the time; he only formally received the Nobel diploma and lecture after the Second World War, in 1947. Domagk's work opened the era of antibacterial chemotherapy that preceded the wider adoption of penicillin.
Gerhard Domagk
Filter Results1 entry
Connections
In the Other Atlases
Nationality
Also in Geography Atlas: the nationality of this subject.
Source Wikidata: Gerhard Domagk
Sources
Gerhard Domagk (Wikipedia)
In Group: Experimental Pathologists and Chemotherapy Pioneers, Introduction, sentences 1-2Quote, In Group: Experimental Pathologists and Chemotherapy Pioneers, Introduction, sentences 1-2
Gerhard Johannes Paul Domagk (German pronunciation: [ˈɡeːɐ̯haʁt ˈdoːmak] ; 30 October 1895-24 April 1964) was a German pathologist and bacteriologist. He is credited with the discovery of sulfonamidochrysoidine (KL730) as an antibiotic for which he received the 1939 Nobel Prize in Physiology or Medicine.
View the Source Wikidata: Gerhard Domagk
- Wikidata Q57192, class allow-list match (w-wdresolver-0926)
- Wikidata P569 (w-bbfill-medicine3-0926)
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.